Drug-Induced Ocular Side Effects: Clinical Ocular Toxicology (8th Edition)

Description

Written by global experts in the field of chemical- and drug-related ocular problems, Drug-Induced Ocular Side Effects, 8th Edition, provides need-to-know information on all aspects of ocular toxicology in one concise reference. This best-selling, user-friendly resource features a templated format, numerous full-color illustrations, and sweeping content updates throughout – all designed to eliminate uncertainty and ensure accurate diagnosis and treatment guidance.

Key Features

•  Provides comprehensive coverage of drugs’ generic and trade names, primary uses, ocular and systemic side effects, and clinical significance.
• Features a unique side effect index, a new concise paperback format for portability, and clinical photos of ocular symptoms of adverse drug reactions.
• Covers dozens of new drugs used in the U.S. and internationally, as well as extensive updates to drug registry information to ensure access to the latest data.
• Includes expanded sections on how to follow patients with visual adverse drug reactions to chloroquine, hydroxychloroquine, isotretinoin, ethambutol, and more. Guidelines can be copied to use as patient handouts.
• Offers extensive discussions of principles of therapy, ocular drug delivery, methods to evaluate drug-induced visual side effects, and the role of electrophysiology and psychophysics.
• Provides the WHO classification system to help you determine whether a particular side effect is certain, probable, or likely to occur.
• Ideal for ophthalmologists, optometrists, and busy clinicians in primary care, emergency medicine, and more – anyone who needs quick, on-the-spot consultation on ocular toxicology.
• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Table of Contents

1.  Preface
2. List of Contributors
3. Instructions to Users
4. Chapter 1. National Registry of Drug-Induced Ocular Side Effects
   1. Rationale
   2. Objectives of the National Registry of Drug-Induced Ocular Side Effects
   3. How to Report a Suspected Reaction
5. Chapter 2. Ocular Drug Delivery and Toxicology
   1. Topical Ocular Administration
   2. Basic Pharmacology and Toxicology of Topical Medications
   3. Intraocular Distribution
   4. Preservatives
   5. Vehicles for Topical Ocular Medication Delivery
   6. Toxicity Responses
   7. How to Apply Topical Ocular Medication
6. Chapter 3. Methods for Evaluating Drug-Induced Visual Side Effects
   1. Risk
   2. Selecting Diagnostic Tests
   3. Frequency
   4. Topical Administration
   5. Order of Testing
   6. Timing of Testing
   7. Functional Tests
   8. Objective Anatomic Methods
   9. Number of Patients to Test
   10. Summary
7. Chapter 4. Anti-Infectives
   1. Class: Amebicides
   2. Class: Anthelmintics
   3. Class: Antibiotics
   4. Class: Antifungal Drugs
   5. Class: Antileprosy Drugs
   6. Class: Antimalarial Drugs
   7. Management of Antimalarials to Minimize Retinopathy
8. Chapter 5. Drugs Affecting the Central Nervous System
   1. Class: Analeptics
   2. Class: Anorexiants
   3. Class: Antianxiety Drugs
   4. Class: Anticonvulsants
   5. Class: Antidepressants
   6. Class: Anti–Multiple Sclerosis Drugs
   7. Class: Antipsychotic Drugs
   8. Class: Depressants
   9. Class: Genitourinary Tract Drugs
   10. Class: Psychedelic Drugs
   11. Class: Sedatives and Hypnotics
9. Chapter 6. Drugs Affecting the Autonomic Nervous System
   1. Class: Stimulants
10. Chapter 7. Analgesics, Narcotic Antagonists, and Drugs Used to Treat Arthritis
    1. Class: Drugs Used to Treat Gout
    2. Class: Antirheumatic Drugs
    3. Class: Mild Analgesics
    4. Class: Narcotic Antagonists
    5. Class: Strong Analgesics
11. Chapter 8. Drugs Used in Anesthesia
    1. Class: Adjuncts to Anesthesia
    2. Class: General Anesthesia
    3. Class: Local Anesthetics
    4. Class: Therapeutic Gases
12. Chapter 9. Gastrointestinal Drugs
    1. Class: Drugs Used to Treat Acid Peptic Disorders
    2. Class: Antacids
    3. Class: Antiemetics
    4. Class: Antilipidemic Drugs
    5. Class: Antispasmodics
    6. Class: Gastrointestinal and Urinary Tract Stimulants
13. Chapter 10. Cardiac, Vascular, and Renal Drugs
    1. Class: Drugs Used to Treat Migraine
    2. Class: Antianginal Drugs
    3. Class: Antiarrythmic Drugs
    4. Class: Antihypertensive Drugs
    5. Class: Bronchodilators
    6. Class: Diuretics
    7. Class: Osmotics
    8. Class: Peripheral Vasodilators
    9. Class: Vasopressors
14. Chapter 11. Hormones and Drugs Affecting Hormonal Mechanisms
    1. Class: Adrenal Corticosteroids
    2. Class: Androgens
    3. Class: Antithyroid Drugs
    4. Class: Erectile Dysfunction Drugs
    5. Class: Estrogens and Progestogens
    6. Class: Ovulatory Drugs
    7. Class: Thyroid Hormones
15. Chapter 12. Drugs Affecting Blood Formation and Coagulability
    1. Class: Drugs Used to Treat Deficiency Anemias
    2. Class: Anticoagulants
    3. Class: Blood Substitutes
16. Chapter 13. Homeostatic and Nutrient Drugs
    1. Class: Drugs Used to Treat Hyperglycemia
17. Chapter 14. Drugs Used to Treat Allergic and Neuromuscular Disorders
    1. Class: Drugs Used To Treat Myasthenia Gravis
    2. Class: Antihistamines
    3. Class: Antiparkinsonism Drugs
    4. Class: Cholinesterase Reactivators
    5. Class: Muscle Relaxants
18. Chapter 15. Oncolytic Drugs
    1. Class: Antineoplastic Drugs
19. Chapter 16. Heavy Metal Antagonists and Miscellaneous Drugs
    1. Class: Drugs Used to Treat Alcoholism
    2. Class: Calcium-Regulating Drugs
    3. Class: Chelating Drugs
    4. Class: Diagnostic Aids
    5. Class: Immunosuppressants
    6. Class: Retinoids
    7. Class: Solvents
    8. Class: Vaccines
20. Chapter 17. Drugs Used in the Management of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
    1. Class: Antiretroviral Drugs
21. Chapter 18. Drugs Used in Ophthalmology
    1. Class: Drugs Used to Treat Age-Related Macular Degeneration
    2. Class: Drugs Used to Treat Allergies
    3. Class: Drugs Used to Treat Glaucoma
    4. Class: Anti-Infectives
    5. Class: Antiviral Drugs
    6. Class: Carbonic Anhydrase Inhibitors
    7. Class: Decongestants
    8. Class: Miotics
    9. Class: Mydriatics and Cycloplegics
    10. Class: Neurotoxins
    11. Class: Ophthalmic Dyes
    12. Class: Ophthalmic Implants and Injectable Gases
    13. Class: Ophthalmic Preservatives and Antiseptics
    14. Class: Proteolytic Enzymes
    15. Class: Surgical Adjuncts
    16. Class: Topical Local Anesthetics
    17. Class: Topical Ocular Nonsteroidal Anti-Inflammatory Drugs
    18. Class: Topical Osmotic Drugs
    19. Class: Viscoelastics
22. Chapter 19. Herbal Medicine– and Dietary Supplement–Induced Ocular Side Effects
    1. Herbal or Supplement Names:
    2. Index of Side Effects
    3. Subject Index

Authors Biography

 Frederick T. Fraunfelder

Affiliations and Expertise

Professor Emeritus, Department of Ophthalmology; Founder, National Registry of Drug Induced Ocular Side Effects; Consultant, World Health Organization; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA

Frederick W. Fraunfelder

Affiliations and Expertise

Chairman and Roy E. Mason and Elizabeth Patee Mason Distinguished Professor of Ophthalmology, Department of Ophthalmology, Missouri University School of Medicine; Director, National Registry of Drug-Induced Ocular Side Effects; Consultant, World Health Organization; Director, Missouri University Health Care’s Mason Eye Institute, Columbia, Missouri, USA